Purpose: [corrected] Management of the side effect profiles of the new oral cancer chemotherapeutic agents differs from those of traditional oral chemotherapy and hormonal therapy. The healthcare practitioner's role in counseling and managing these toxicities as well as methods for assessing and promoting adherence is reviewed.
Summary: Many side effects from traditional oral cancer chemotherapeutic agents are the result of their effects on healthy cells as well as cancer cells.
Objective: To review the normal coagulation process and the mechanisms that lead to abnormal clotting.
Data Sources: Primary and tertiary literature and the authors' clinical experience.
Conclusion: The process of coagulation is complex and can be easily misunderstood.
Objectives: To provide a general overview of chemotherapy-induced diarrhea (CID) that will highlight the pathophysiology, incidence, and impact of this problem, as well as describe the oncology nurse's role in the management of CID.
Data Sources: Primary and tertiary literature, the authors' clinical experience.
Conclusion: CID is a frequent complication of many types of chemotherapy that can significantly affect patient quality of life, increase treatment costs, and limit the ability to deliver full doses of chemotherapy.
Objective: To review the clinical presentation, current methods of diagnosis and classification, treatment modalities, and novel treatment approaches of acute myelogenous and lymphoblastic leukemia.
Data Sources: Professional journals, web sites, and books.
Conclusion: The incidence of acute leukemia is increasing.